Biorelease deal

BREL announced plans to spin off its blood substitute and drug delivery assets, after which it will engage in a new business of acquiring companies and technology under a new name, Pharmatrage Holdings Inc.

In connection with the changes, BREL signed a letter of intent to acquire TheraMed, a company recently created to focus on consolidation of biopharmaceutical technologies and companies. ...